Meeting
2014 Genitourinary Cancers Symposium
Antigen spread and survival with sipuleucel-T in patients with advanced prostate cancer.
Authors
Charles G. Drake
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
Charles G. Drake , Li-Qun Fan , Debraj GuhaThakurta , Frances Stewart , Philip W. Kantoff , Eric Jay Small , Thomas A. Gardner , Nadeem A. Sheikh , James B. Trager , Celestia S. Higano
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Clinical Trial Registration Number
NCT00065442
Citation
J Clin Oncol 32, 2014 (suppl 4; abstr 88)
DOI
10.1200/jco.2014.32.4_suppl.88
Abstract #
88
Poster Bd #
F5
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
HB-300, a novel arenavirus-based cancer immunotherapy in patients with metastatic castration-resistant prostate cancer.
First Author: David D. Chism
Poster
2017 Genitourinary Cancers Symposium
Antigen spread (AgS) after sipuleucel-T (sip-T): A cross-trial comparison of 4 sip-T clinical trials of patients (pts) with prostate cancer (PC).
First Author: Lawrence Fong
Poster
2024 ASCO Genitourinary Cancers Symposium
Nucleosome profiling at AR binding sites (ARBS) to provide a prognostic tool for metastatic castration-resistant prostate cancer (mCRPC).
First Author: Chao Dai
Poster
2024 ASCO Genitourinary Cancers Symposium
Effect of combined treatment with sipuleucel-T and IL-15 on tumor control, tumor-infiltrating immune effectors, and key mediators of immunoresistance in a preclinical prostate cancer model.
First Author: Russell Kent Pachynski